Related Experiment Video
Updated: Jul 16, 2025
09:48
Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
4.4K
Research progress on mesenchymal stem cells and their exosomes in systemic sclerosis
Yan Zhang1, Yanli Yang1, Xiang Gao1
1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Frontiers in Pharmacology
|September 11, 2023
Summary
Mesenchymal stem cells (MSCs) and their secreted exosomes show promise for treating systemic sclerosis (SSc). These therapies offer immunomodulatory and antifibrotic benefits, potentially overcoming limitations of current SSc treatments.
Area of Science:
- Connective tissue diseases
- Immunology
- Regenerative Medicine
Background:
- Systemic sclerosis (SSc) is a fibrotic connective tissue disease with unknown causes.
- Current SSc treatments have limited efficacy and significant side effects.
- Pathogenesis involves microvascular injury, inflammation, and fibroblast activation.
Purpose of the Study:
- To review the latest research on mesenchymal stem cells (MSCs) for SSc treatment.
- To explore the therapeutic potential of exosomes derived from MSCs in SSc.
- To offer novel treatment strategies for SSc.
Main Methods:
- Review of current literature on MSCs and exosomes in SSc.
- Analysis of MSC properties: immunomodulatory, antifibrotic, pro-angiogenic.
- Evaluation of exosome characteristics: targeted delivery, low immunogenicity, stability.
Main Results:
- MSCs demonstrate significant therapeutic potential for SSc.
- Exosomes derived from MSCs offer advantages over MSCs, including safety and stability.
- Exosomes can overcome limitations associated with direct MSC transplantation.
Conclusions:
- MSCs and their exosomes represent promising therapeutic avenues for SSc.
- Further research into exosome preparation and delivery systems is crucial.
- This review provides insights for developing novel SSc treatments.
Keywords:
exosomesmesenchymal stem cellsother organ involvementpulmonary interstitial fibrosisskin fibrosissystemic sclerosisvascular injuryMore Related Videos
Related Concept Videos
01:19Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K